GlcCer (d18:1/24:1) is an oligoglycosylceramide that can be used in the research of potential adjuvant development for vaccination against infectious diseases.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
